Palisade Capital Management LLC Regeneron Pharmaceuticals, Inc. Transaction History

Palisade Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $331,789 - $393,594	-578 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$472.8 - $558.54 $330,960 - $390,978	-700 Reduced 54.77%	578 $323,000
Q1 2021 May 12, 2021	SELL	$446.73 - $548.2 $11,168 - $13,705	-25 Reduced 1.92%	1,278 $605,000
Q4 2020 Feb 11, 2021	BUY	$478.3 - $607.98 $59,787 - $75,997	125 Added 10.61%	1,303 $629,000
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $641,715 - $775,371	1,178 New	1,178 $659,000
Q2 2020 Aug 06, 2020	SELL	$493.32 - $643.92 $679,794 - $887,321	-1,378 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$336.18 - $494.43 $463,256 - $681,324	1,378 New	1,378 $673,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Palisade Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Palisade Capital Management LLC with notifications on news.